| Literature DB >> 21475124 |
Sook Wah Tang1, Mohd Aspollah Sukari, Mawardi Rahmani, Nordin Hj Lajis, Abdul Manaf Ali.
Abstract
A new abietene diterpene, kaempfolienol (5S,6S,7S,9S,10S,11R,13S-abiet-8(14)-enepenta-6,7,9,11,13-ol, 1), was isolated from a rhizome extract of Kaempferia angustifolia Rosc. along with the known compounds crotepoxide, boesenboxide, zeylenol, 2'-hydroxy-4,4',6'-trimethoxychalcone, (24S)-24-methyl-5α-lanosta-9(11),25-dien-3β-ol, β-sitosterol and β-sitosterol-3-O-β-D-glucopyranoside. The structures of all compounds were elucidated on the basis of mass spectroscopic and NMR data. Zeylenol (2), the major constituent of the plant, was derivatized into diacetate, triacetate and epoxide derivatives through standard organic reactions. The cytotoxic activity of compounds 1, 2 and the zeylenol derivatives was evaluated against the HL-60, MCF-7, HT-29 and HeLa cell lines.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21475124 PMCID: PMC6260639 DOI: 10.3390/molecules16043018
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of compounds.
Figure 2COSY and HMBC correlations of compound 1.
1H-NMR (500 MHz) and 13C-NMR (125 MHz) spectral data of kaempfolienol (1) (CD3OD).
| Position | 1H-NMR δ (multiplicity,
| COSY | 13C -NMR (δ) | HMBC | |
|---|---|---|---|---|---|
|
2
|
3
| ||||
| 1 | 1.55 ( | - | 37.1 | C-2 | C-9 |
| 1.76 ( | |||||
| 2 | 1.46 ( | - | 20.0 | - | - |
| 1.66 ( | |||||
| 3 | 1.25 (br | - | 45.0 | - | C-1 |
| 1.33 (br | |||||
| 4 | - | - | 35.0 | - | - |
| 5 | 1.96 ( | H-6 | 44.3 | C-6, C-4,C-10 | C-9, C-20,C-18, C-3 |
| 6 | 4.18 ( | H-5, H-7 | 73.1 | C-7 | C-10, C-8 |
| 7 | 3.89 ( | H-6 | 81.2 | C-6, C-8 | C-5, C-9, C-14 |
| 8 | - | - | 139.9 | - | - |
| 9 | - | - | 78.0 | - | - |
| 10 | - | - | 45.0 | - | - |
| 11 | 4.35 ( | H-12 | 65.4 | C-12 | C-10 |
| 12 | 1.61 ( | H-11 | 37.6 | C-13, C-11 | C-14, C-9, C-15 |
| 1.63 ( | |||||
| 13 | - | - | 73.3 | - | - |
| 14 | 5.78 ( | H-12 | 135.8 | C-13 | C-7, C-9, C-12, C-15 |
| 15 | 1.71 ( | H-16, H-17 | 39.3 | C-13, C-16 | C-12, C-14 |
| 16 | 0.96 ( | H-15 | 16.9 | C-15 | C-13, C-17 |
| 17 | 0.93 ( | H-15 | 17.6 | C-15 | C-13, C-16 |
| 18 | 1.27 ( | - | 25.0 | C-4 | C-3, C-19 |
| 19 | 1.02 ( | - | 34.3 | C-4 | C-18, C-5, C-3 |
| 20 | 1.21 ( | - | 21.2 | C-10 | C-9, C-1 |
Cytotoxic activity of compounds against HL-60, MCF-7, HT-29 and HeLa cells.
| IC50(μg/mL) | ||||
|---|---|---|---|---|
| Compounds | HL-60 | MCF-7 | HT-29 | HeLa |
|
| 24.22 ± 0.30 | 23.50 ± 1.70 | - | - |
|
| 11.65 ± 0.52 | - | - | - |
|
| - | - | 6.73 ± 0.68 | - |
|
| - | - | - | - |
|
| 20.91 ± 1.28 | - | NT | - |
|
| ||||
| Goniothalamin | 1.23 ± 0.20 | |||
| 5-Fluorouracil | 4.20 ± 0.30 | |||
| Tamoxifen | 3.12 ± 0.20 | 1.10 ± 0.21 | ||
Notes: HL-60 (Human Promyelocytic Leukemia), MCF-7 (Human Breast Cancer), HT-29 (Human Colon Cancer), HeLa (Human Cervical Leukemia).
- : not active, IC50 > 30 μg/mL; NT: not tested.
* Results are expressed as IC50 values (μg/mL) ± Standard deviation of three experiments performed in triplicate.